| [1] |
HAN Leyang, ZHENG Huixian, TIAN Yiran, TANG Haoqing, LONG Ren, LI Daihan, LIU Xiaoyun.
Measuring Integrated Services for Rural Chronic Disease Patients Based on Formative Measurement Theory
[J]. Chinese General Practice, 2026, 29(31): 4543-4550.
|
| [2] |
TIAN Xiangyang, ZHOU Yingsheng, GAO Ying.
Prospects of Behavioral and Lifestyle Interventions for Diabetes Mellitus
[J]. Chinese General Practice, 2026, 29(31): 4513-4520.
|
| [3] |
KUANG Li, DING Xinxin, MA Yuanzhu.
Application of Motivational Interviewing in Healthcare Provider-Patient Communication for Chronic Disease Management in Primary Care: from Principles to Practice
[J]. Chinese General Practice, 2026, 29(31): 4536-4542.
|
| [4] |
LI Xiling, ZHANG Fan, YANG Xinyue, YANG Heng.
Application of Exercise Snacks in Chronic Disease Management: a Scoping Review
[J]. Chinese General Practice, 2026, 29(30): 4472-4479.
|
| [5] |
GUO Junchi, ZHANG Mingyan, QIN Guangning, XU Qiang, LU Meijuan.
Preliminary Application of the Novel Biomarker TANS01 in Cardiovascular Risk Assessment among Individuals with Phlegm-dampness Constitution
[J]. Chinese General Practice, 2026, 29(27): 3924-3930.
|
| [6] |
FU Mengru, XUE Meiqiyang, JIANG Yutong, CHEN Mingsheng, QIAN Dongfu, LI Zhong.
Study on the Influencing Factors of Self-management Ability of Atrial Fibrillation Patients in Rural Areas
[J]. Chinese General Practice, 2026, 29(27): 3947-3955.
|
| [7] |
WANG Wei, YU Fei, YAN Xiaohong.
Application and Mechanisms of Sodium-glucose Cotransporter 2 Inhibitors in Heart Failure with Different Etiologies: Evidence from Ischemic and Non-ischemic Heart Failure
[J]. Chinese General Practice, 2026, 29(27): 3976-3984.
|
| [8] |
ZHAO Yiru, HAO Xinyu, ZHAO Lei, ZHANG Caihui, WANG Zhaoxia, ZHANG Yueying.
Summary of the Best Evidence for the Management of Diuretic Resistance in Patients with Heart Failure
[J]. Chinese General Practice, 2026, 29(25): 3694-3703.
|
| [9] |
XUE Cuirong, WEI Wei, WU Renyuan, XUE Yaqin, XU Huijiang, LYU Weijiang, JIANG Dandan.
Prevalence and Management Status of Chronic Kidney Disease in Hypertensive and Type 2 Diabetic Populations: a Community-based Cross-sectional Study
[J]. Chinese General Practice, 2026, 29(25): 3650-3654.
|
| [10] |
LI Xueni, LIU Gejing, LIU Yongming.
Efficacy and Safety of Semaglutide in Patients with Heart Failure: a Meta-Analysis
[J]. Chinese General Practice, 2026, 29(24): 3509-3519.
|
| [11] |
CHENG Yu, HAN Shiyao, SUN Ping, XIANG Juan, YANG Hui, LI Dongze, ZHENG Li, LIAO Xiaoyang.
Analysis of Socioeconomic and Demographic Challenges in Chronic Disease Management
[J]. Chinese General Practice, 2026, 29(20): 2800-2807.
|
| [12] |
CHEN Qiulong, CHEN Jia, FANG Jing, DAI Wei, YANG Qing.
Application Status and Research Progress of Observer-reported Outcome
[J]. Chinese General Practice, 2026, 29(18): 2561-2570.
|
| [13] |
LI Shilong, WANG He, ZHOU Xiaoyu, FU Lei, ZHAO Zhuo, HUA Chengjun, SI Chunying.
Advances in the Study of Cardiac Macrophages in Heart Failure with Preserved Ejection Fraction
[J]. Chinese General Practice, 2026, 29(15): 2084-2091.
|
| [14] |
YANG Rong, JIN Hua, SHI Ling, YI Chuntao, HOU Jin, CHEN Chen, HUAN Hongmei, NI Hengru, YU Dehua.
A Survey on the Quality of Diabetes Normative Management at Grassroots Level
[J]. Chinese General Practice, 2026, 29(12): 1541-1547.
|
| [15] |
JIAO Xitong, LIU Lu, GUO Jiayue, YOU Lili.
Prospects for the Application of Digital Therapy Products for Hypertension at Home and Abroad and the Implications for China
[J]. Chinese General Practice, 2026, 29(10): 1354-1360.
|